Nongo, Aldrin .
HRN: 05-91-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/09/2024
09/15/2024
IV
600mg
Q8 X7days
Possible Tendon Tear Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes